loader
Please Wait
Applying Filters...
Close
4

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Information, Expiry & Status of Health Canada Patents covering Ibrutinib.

    Client Email Product
    Menu

    Ibrutinib

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Forms

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass

    PharmaCompass Sponsored Ads

    PharmaCompass Sponsored Ads

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Janssen Inc. (1)

    filter

    01 2663116 (1)

    filter

    01 Ibrutinib (1)

    filter

    01 CAPSULE (IMMEDIATE RELEASE) (1)

    filter

    01 2026-12-28 (1)

    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Janssen Inc.

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Ibrutinib

    PDF Supplier PDF
    URL Supplier Web Content
    2663116
    140 mg
    CAPSULE (IMMEDIATE RELEASE)
    Human
    2026-12-28
    2014-10-06
    2006-12-28
    IMBRUVICA
    ORAL
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Post Enquiry
    POST ENQUIRY